共 50 条
- [1] Reply to: ‘Interaction between RAAS inhibitors and ACE2 in the context of COVID-19’ Nature Reviews Cardiology, 2020, 17 : 313 - 314
- [5] ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases Inflammation Research, 2023, 72 : 1719 - 1731
- [8] COVID-19, ACE2, and the cardiovascular consequences AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (05): : H1084 - H1090